Exendin affects beta-cell function and insulin secretion
the verdict
SUPPORTED
the evidence backs this
confidence 78/100
Exendin analogs consistently demonstrate positive effects on beta-cell function, survival, and insulin secretion across multiple experimental and clinical studies.
Evidence for · 5
Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
2026 · cited by 2
Paper 1 demonstrates that exendin-based tracers bind to pancreatic beta cells and correlate with beta-cell function markers like C-peptide and glycemic control.
See more details
More for · 4
Exendin-4 improves high glucose-induced mitochondrial dysfunction of pancreatic β-cells via PKA/Drp1 signaling.
2026 · cited by 0
Paper 4 shows that exendin-4 protects beta cells from mitochondrial dysfunction and improves glucose-stimulated insulin secretion.
Unimolecular GLP-1/Apelin Hybrid Peptides Cause Prominent Appetite Suppression, as Well as Enhancing Insulin Secretion, Beta-Cell Survival and Glycaemic Regulation.
2026 · cited by 0
Paper 5 reports that exendin-4 hybrid peptides enhance insulin secretion and promote beta-cell survival.
Structural determinants of beta-cell failure in type 2 diabetes: a multimodality imaging study.
2026 · cited by 0
Paper 7 links exendin-4 PET/CT estimates of beta-cell mass to insulin secretion rates in patients.
Med14 phosphorylation shapes genomic response to GLP-1 agonists.
2026 · cited by 0
Paper 10 notes that chronic exposure to exendin-4 stimulates sustained gene expression leading to increased beta-cell viability and insulin secretion.